These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 1462980)
1. Diabetic nephropathy in insulin-dependent patients. Breyer JA Am J Kidney Dis; 1992 Dec; 20(6):533-47. PubMed ID: 1462980 [TBL] [Abstract][Full Text] [Related]
2. Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention. Baba T; Neugebauer S; Watanabe T Drugs; 1997 Aug; 54(2):197-234. PubMed ID: 9257079 [TBL] [Abstract][Full Text] [Related]
3. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Steinke JM; Mauer M; Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710 [TBL] [Abstract][Full Text] [Related]
4. Hypertension in insulin-dependent diabetes. Norgaard K Dan Med Bull; 1996 Feb; 43(1):21-38. PubMed ID: 8906979 [TBL] [Abstract][Full Text] [Related]
5. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus]. Lehmann R; Spinas GA Praxis (Bern 1994); 1995 Oct; 84(44):1265-71. PubMed ID: 7491450 [TBL] [Abstract][Full Text] [Related]
6. Glomerular dysfunction in diabetic nephropathy. Zucchelli P; Zuccalà A; Sturani A Postgrad Med J; 1988; 64 Suppl 3():22-30; discussion 48-9. PubMed ID: 3074295 [TBL] [Abstract][Full Text] [Related]
7. Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study. Yip JW; Jones SL; Wiseman MJ; Hill C; Viberti G Diabetes; 1996 Dec; 45(12):1729-33. PubMed ID: 8922358 [TBL] [Abstract][Full Text] [Related]
8. Comparative renal pathophysiology relevant to IDDM and NIDDM patients. Mogensen CE; Schmitz A; Christensen CK Diabetes Metab Rev; 1988 Aug; 4(5):453-83. PubMed ID: 3061756 [TBL] [Abstract][Full Text] [Related]
10. Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria? Mogensen CE Diabetes; 1990 Jul; 39(7):761-7. PubMed ID: 2191882 [TBL] [Abstract][Full Text] [Related]
11. Concerns about diabetic nephropathy in the treatment of diabetic hypertensive patients. Tolins JP; Raij L Am J Med; 1989 Dec; 87(6A):29S-33S. PubMed ID: 2688411 [TBL] [Abstract][Full Text] [Related]
12. Diabetic nephropathy--prevention and treatment. Agarwal DK J Indian Med Assoc; 2002 Mar; 100(3):158-60, 162-3. PubMed ID: 12408275 [TBL] [Abstract][Full Text] [Related]
16. Hyperfiltration and diabetic nephropathy: is it the beginning? Or is it the end? Castellino P; Shohat J; DeFronzo RA Semin Nephrol; 1990 May; 10(3):228-41. PubMed ID: 2190280 [TBL] [Abstract][Full Text] [Related]
18. Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy. Passariello N; Sepe J; Marrazzo G; De Cicco A; Peluso A; Pisano MC; Sgambato S; Tesauro P; D'Onofrio F Diabetes Care; 1993 May; 16(5):789-95. PubMed ID: 8495620 [TBL] [Abstract][Full Text] [Related]
19. Renal protection and antihypertensive drugs: current status. Salvetti A; Mattei P; Sudano I Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294 [TBL] [Abstract][Full Text] [Related]
20. The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy. Mulec H; Blohmé G; Grände B; Björck S Nephrol Dial Transplant; 1998 Mar; 13(3):651-5. PubMed ID: 9550642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]